Skip to main content
. 2017 May 3;12(5):e0177198. doi: 10.1371/journal.pone.0177198

Fig 1. Reduced expression of PCAT29 expression in prostate cancer cells and tumor tissues.

Fig 1

(A) Relative mRNA levels of PCAT29 in normal human prostate epithelial cells (RWPE-1) and prostate cancer cells (LNCaP and DU145). The levels of PCAT29 were significantly reduced in prostate cancers cells compared to RWPE-1 cells. (n≥3) (B) Significant reductions in PCAT29 levels in normal prostate tissues compared to prostate cancer. Data are presented as the mean ± SEM of 4 prostate samples. Asterisks (*) indicate statistically significantly difference (p < 0.05) from RWPE-1 and from normal prostate tissue, respectively. (**) indicate statistically significantly difference (p < 0.05) from LNCaP cells.